AlphaVest Acquisition Corp Ordinary Shares (ATMV) - Total Liabilities
Based on the latest financial reports, AlphaVest Acquisition Corp Ordinary Shares (ATMV) has total liabilities worth $5.26 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AlphaVest Acquisition Corp Ordinary Shar (ATMV) net asset momentum to track the company's year-over-year net asset growth rate.
AlphaVest Acquisition Corp Ordinary Shares - Total Liabilities Trend (2022–2024)
This chart illustrates how AlphaVest Acquisition Corp Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does AlphaVest Acquisition Corp Ordinary Shar generate to measure how efficiently the company converts operating cash flow to free cash.
AlphaVest Acquisition Corp Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of AlphaVest Acquisition Corp Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fredonia Mining Inc
V:FRED
|
Canada | CA$815.01K |
|
Ozaurum Resources Ltd
AU:OZM
|
Australia | AU$493.01K |
|
ATP 30 Public Company Limited
BK:ATP30
|
Thailand | ฿667.54 Million |
|
Initiator Pharma A/S
ST:INIT
|
Sweden | Skr4.37 Million |
|
Voyageur Pharmaceuticals Ltd
V:VM
|
Canada | CA$1.85 Million |
|
Neurosense Therapeutics Ltd
NASDAQ:NRSN
|
USA | $2.59 Million |
|
Zhonglu Co Ltd B
SHG:900915
|
China | $530.49 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down AlphaVest Acquisition Corp Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AlphaVest Acquisition Corp Ordinary Shar (ATMV) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AlphaVest Acquisition Corp Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AlphaVest Acquisition Corp Ordinary Shares (2022–2024)
The table below shows the annual total liabilities of AlphaVest Acquisition Corp Ordinary Shares from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.75 Million | +352.02% |
| 2023-12-31 | $387.95K | +126.68% |
| 2022-12-31 | $171.15K | -- |
About AlphaVest Acquisition Corp Ordinary Shares
AlphaVest Acquisition Corp does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2022 and is based in New York, New York.